Neologics Bioscience Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC
  • (Announced)

  • Latest Deal Amount
  • $1M

  • Investors
  • 9

Neologics Bioscience General Information

Description

Developer of innovative biological medicines for immune regulation. The company uses immune regulation target verification and screening platform to develop innovative bio-pharmaceuticals and bio-markers, enabling the hospitals to meet clinical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 401, Building B6
  • Number 218 Xinghu Street
  • Suzhou, Jiangsu 215121
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Room 401, Building B6
  • Number 218 Xinghu Street
  • Suzhou, Jiangsu 215121
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neologics Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 21-Oct-2025 $1M Announced Generating Revenue
4. Early Stage VC 29-Dec-2021 Completed Generating Revenue
3. Early Stage VC 27-Aug-2021 Completed Generating Revenue
2. Early Stage VC 30-Dec-2019 Completed Generating Revenue
1. Early Stage VC 23-Sep-2019 Completed Generating Revenue
To view Neologics Bioscience’s complete valuation and funding history, request access »

Neologics Bioscience Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Elikon Venture Growth/Expansion Minority
Jiangsu Tongren Boda Private Equity Fund Management Venture Capital Minority
Nanometer Venture Venture Capital Minority
Xiangtang Ventures Corporate Venture Capital Minority
Yonghua Capital Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Neologics Bioscience FAQs

  • When was Neologics Bioscience founded?

    Neologics Bioscience was founded in 2018.

  • Where is Neologics Bioscience headquartered?

    Neologics Bioscience is headquartered in Suzhou, China.

  • What industry is Neologics Bioscience in?

    Neologics Bioscience’s primary industry is Drug Discovery.

  • Is Neologics Bioscience a private or public company?

    Neologics Bioscience is a Private company.

  • What is the current valuation of Neologics Bioscience?

    The current valuation of Neologics Bioscience is .

  • What is Neologics Bioscience’s current revenue?

    The current revenue for Neologics Bioscience is .

  • Who are Neologics Bioscience’s investors?

    Elikon Venture, Jiangsu Tongren Boda Private Equity Fund Management, Nanometer Venture, Xiangtang Ventures, and Yonghua Capital are 5 of 9 investors who have invested in Neologics Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process